TrialRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2024

A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors.

Christopher A Barker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.